MEDPACE HOLDINGS INC

NASDAQ: MEDP (Medpace Holdings, Inc.)

Last update: 2 days ago, 7:43PM

372.00

-2.32 (-0.62%)

Market Trend

Short Term Medium Term
Industry Diagnostics & Research (US) Bullish -
Diagnostics & Research (Global) Bullish Bearish
Stock Medpace Holdings, Inc. - -

Medpace is a late-stage contract research organization, or CRO, that provides full-service drug development and clinical trial services to small and midsized biotechnology, pharmaceutical, and medical device firms. Medpace also offers ancillary services such as bio-analytical laboratory services and imaging capabilities. The company was founded over 30 years ago, and it has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are principally based in the U.S., but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in February 2014, and it exited Medpace in August 2018.

Sector Healthcare
Industry Diagnostics & Research
Investment Style Mid Growth

Ownership

Name Date Shares Held
American Capital Management Inc 31 Dec 2023 395,120
Bessemer Group Inc 31 Dec 2023 388,697
52 Weeks Range
186.73 - 419.42
Price Target Range
395.00 - 480.00
High 480.00 (UBS, 29.03%) Buy
Median 408.00 (9.68%)
Low 395.00 (Deutsche Bank, 6.18%) Hold
Average 427.67 (14.96%)
Total 1 Hold, 1 Outperform, 1 Buy
Firm Date Target Price Call Price @ Call
Deutsche Bank 18 Mar 2024 395.00 (6.18%) Hold 390.92
UBS 08 Mar 2024 480.00 (29.03%) Buy 405.65
15 Feb 2024 452.00 (21.51%) Buy 394.34
Baird 14 Feb 2024 408.00 (9.68%) Outperform 389.80

No data within this time range.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No data